LBF20406LT04

LipidBank Top (トップ)

Fatty acid (脂肪酸)

Glycerolipid (グリセロ脂質)

Sphingolipid (スフィンゴ脂質)

Journals (雑誌一覧)

How to edit (ページの書き方)

Upper classes: LB LBF

IDs and Links
LipidBank	XPR3113
LipidMaps	LMFA03020011
CAS
KEGG	{{{KEGG}}}
KNApSAcK	{{{KNApSAcK}}}
mol	LBF20406LT04

Leukotriene B4dimethylamide
Structural Information
Systematic Name	N,N-Dimethyl- (5S,12R) -dihydroxy- (6-cis,8-trans,11-trans,14-cis) -icosatetraenamide
Common Name	Leukotriene B4dimethylamide N,N-Dimethyl- (5S,12R) -dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenamide
Symbol
Formula	C22H37NO3
Exact Mass	363.27734405499996
Average Mass	363.53412000000003
SMILES	C(=CC[C@@H](O)C=CC=CC=C[C@H](CCCC(N(C)C)=O)O)CCCCC
Physicochemical Information
Melting Point
Boiling Point
Density
Optical Rotation
Refractive Index
Solubility
Source
Chemical Synthesis
Metabolism
Biological Activity	Leukotriene B4 dimethylamide inhibits LTB4 induced degranulation of human neutrophils at the concentration of 130 nM (Ki) and release of lysozyme of PMNL. Falcone_RC et al. Shimazaki_T et al. Showell_HJ et al. The effect may be due to the antagonistic effect against LTB4 receptor. Falcone_RC et al.
Genetic Information
Note
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References
Biospecies ID Compound Name Reference Comment n.a. LBF20406LT04 See above. Falcone_RC et al. 1990 n.a. LBF20406LT04 See above. Shimazaki_T et al. 1990 n.a. LBF20406LT04 See above. Showell_HJ et al. 1982